TSC1 and tuberous sclerosis: Our novel mice have a germline heterozygous TSC1 knockout which, when introduced to controlled genetic background diversity, faithfully recapitulates patient heterogeneity in TSC results with the clinically relevant gene dosage and expression pattern.